What it takes for new medicines to access the market
Before a new medical product can be sold in Switzerland, it requires an establishment licence granted by Swissmedic, the Swiss Agency for Therapeutic Products. The authorization procedure is complex, involving a lot of tests and paper work. (swissinfo, Michele Andina)
This content was published on May 11, 2009
Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at email@example.com.